TrialMycoses2025

A Double-Blind Randomised Clinical Trial of Terbinafine-Nanostructured Lipid Carriers: Should We Anticipate This Strategy for Effective Topical Treatment of Onychomycosis?

Shima Parsay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.